©The Author(s) 2025.
World J Orthop. Dec 18, 2025; 16(12): 110291
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.110291
Published online Dec 18, 2025. doi: 10.5312/wjo.v16.i12.110291
Table 5 Overall distribution of clinical scores in patients pre-treatment and at the last follow-up
| Items | Pre-treatment | Post-treatment | χ2 | P value |
| ARCO stage (hips) | ||||
| Stage I | 2 | 2 | 31.966 | < 0.0011 |
| Stage II | 41 | 31 | ||
| Stage IIIa | 59 | 34 | ||
| Stage IIIb | 17 | 39 | ||
| Stage IV | 0 | 13 | ||
| JIC classification (hips) | ||||
| Type A | 12 | 15 | 7.071 | 0.070 |
| Type B | 26 | 21 | ||
| Type C1 | 54 | 51 | ||
| Type C2 | 27 | 32 | ||
| Lesion size (hips) | ||||
| < 15% | 26 | 28 | 5.485 | 0.140 |
| 15%-30% | 37 | 30 | ||
| > 30% | 56 | 61 | ||
| Collapse degree (hips) | ||||
| ≤ 2 mm | 102 | 67 | 25.002 | < 0.001 |
| > 2 mm | 17 | 52 | ||
- Citation: Chen WH, Zhuang C, Guo WJ, Guo WX, He W, Pan Y. Outcomes of the conservative hip preservation treatment in patients with osteonecrosis of the femoral head: With 4-year follow-up. World J Orthop 2025; 16(12): 110291
- URL: https://www.wjgnet.com/2218-5836/full/v16/i12/110291.htm
- DOI: https://dx.doi.org/10.5312/wjo.v16.i12.110291